Pfizer: Drug Recall
Recall #D-0575-2025 · 07/29/2025
Class II: Risk
Recall Details
- Recall Number
- D-0575-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Pfizer
- Status
- Ongoing
- Date Initiated
- 07/29/2025
- Location
- Manhattan, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29, 004 bottles
Reason for Recall
Subpotent drug
Product Description
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Distribution Pattern
Within U.S
Other Recalls by Pfizer
- Class I: Dangerous 12/21/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.